59 related articles for article (PubMed ID: 29718378)
1. Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer.
Li T; Li F; Guo X; Hong C; Yu X; Wu B; Lian S; Song L; Tang J; Wen S; Gao K; Hao M; Cheng W; Su Y; Zhang S; Huang S; Fang M; Wang Y; Ng MH; Chen H; Luo W; Ge S; Zhang J; Xia N; Ji M
N Engl J Med; 2023 Aug; 389(9):808-819. PubMed ID: 37646678
[TBL] [Abstract][Full Text] [Related]
2. DNA-mediated immunization of glycoprotein 350 of Epstein-Barr virus induces the effective humoral and cellular immune responses against the antigen.
Jung S; Chung YK; Chang SH; Kim J; Kim HR; Jang HS; Lee JC; Chung GH; Jang YS
Mol Cells; 2001 Aug; 12(1):41-9. PubMed ID: 11561729
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of gp350/220 conserved domain of epstein barr virus to develop nasopharyngeal carcinoma (npc) vaccine.
Sitompul LS; Widodo N; Djati MS; Utomo DH
Bioinformation; 2012; 8(10):479-82. PubMed ID: 22715303
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.
Hsu WL; Tao J; Fu S; Yu KJ; Simon J; Chen TC; Chen CJ; Goldstein AM; Yu K; Hildesheim A; Waterboer T; Wang CP; Liu Z
Int J Cancer; 2024 Jun; ():. PubMed ID: 38822730
[TBL] [Abstract][Full Text] [Related]
5. Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.
Coghill AE; Hsu WL; Yang Q; Wang CP; Lou PJ; Yu KJ; Yu G; Diehl SR; Chen CJ; Goldstein AM; Hildesheim A
J Gen Virol; 2018 Sep; 99(9):1268-1273. PubMed ID: 29975184
[TBL] [Abstract][Full Text] [Related]
6. Virological Markers in Epstein-Barr Virus-Associated Diseases.
Lupo J; Truffot A; Andreani J; Habib M; Epaulard O; Morand P; Germi R
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992365
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma.
Coghill AE; McGuire A; Sinha S; Homad L; Sinha I; Sholukh A; Koh WP; Yuan JM
Open Forum Infect Dis; 2022 Dec; 9(12):ofac635. PubMed ID: 36519117
[TBL] [Abstract][Full Text] [Related]
8. A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus.
Zhu QY; Shan S; Yu J; Peng SY; Sun C; Zuo Y; Zhong LY; Yan SM; Zhang X; Yang Z; Peng YJ; Shi X; Cao SM; Wang X; Zeng MS; Zhang L
Nat Commun; 2021 Nov; 12(1):6624. PubMed ID: 34785638
[TBL] [Abstract][Full Text] [Related]
9. Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus.
Smith NA; Baresel PC; Jackson CL; Ogolla S; Toko EN; Heit S; Piriou E; Sumba OP; Middeldorp JM; Colborn KL; Rochford R
J Infect Dis; 2019 Feb; 219(6):955-963. PubMed ID: 30312417
[TBL] [Abstract][Full Text] [Related]
10. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
[TBL] [Abstract][Full Text] [Related]
11. Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients.
Shen Y; Zhang S; Sun R; Wu T; Qian J
Emerg Microbes Infect; 2015 Mar; 4(3):e20. PubMed ID: 26038769
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.
Han S; Tay JK; Loh CJL; Chu AJM; Yeong JPS; Lim CM; Toh HC
Front Immunol; 2021; 12():734293. PubMed ID: 34956172
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk.
Coghill AE; Bu W; Hsu WL; Nguyen H; Yu KJ; Chien YC; Chen CJ; Cohen JI; Hildesheim A
J Infect Dis; 2018 Aug; 218(6):886-891. PubMed ID: 29718378
[TBL] [Abstract][Full Text] [Related]
14. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
Hsu WL; Chien YC; Huang YT; Yu KJ; Ko JY; Lin CY; Tsou YA; Leu YS; Liao LJ; Chang YL; Su JY; Liu Z; Wang CP; Terng SD; Hua CH; Lee JC; Yang TL; Kate Hsiao CH; Wu MS; Tsai MH; Liu MJ; Lou PJ; Hildesheim A; Chen CJ;
Cancer Med; 2020 Mar; 9(5):1867-1876. PubMed ID: 31925935
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
